Wuhan Hvsen Biotechnology Co Ltd (300871) — Cash Flow Quality Index
Wuhan Hvsen Biotechnology Co Ltd (300871) has a Cash Flow Quality Index of 0.84x as of September 2025. Operating cash flow of CN¥59.06 Million is below net income of CN¥70.72 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 300871 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wuhan Hvsen Biotechnology Co Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Wuhan Hvsen Biotechnology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 300871 cash flow conversion.
Annual Cash Flow Quality Index for Wuhan Hvsen Biotechnology Co Ltd (2016–2025)
Year-by-year earnings quality comparison for Wuhan Hvsen Biotechnology Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | CN¥238.45 Million | CN¥253.16 Million | ▼ -83.0% |
| 2023 | 5.54x | CN¥92.92 Million | CN¥16.78 Million | ▲ +201.9% |
| 2022 | 1.83x | CN¥96.68 Million | CN¥52.71 Million | ▲ +56.5% |
| 2021 | 1.17x | CN¥155.72 Million | CN¥132.87 Million | ▲ +264.0% |
| 2020 | 0.32x | CN¥48.35 Million | CN¥150.16 Million | ▼ -79.0% |
| 2019 | 1.53x | CN¥105.24 Million | CN¥68.77 Million | ▲ +418.0% |
| 2018 | 0.30x | CN¥21.10 Million | CN¥71.40 Million | ▼ -67.6% |
| 2017 | 0.91x | CN¥80.56 Million | CN¥88.41 Million | ▼ -25.0% |
| 2016 | 1.21x | CN¥60.00 Million | CN¥49.40 Million | — |